Invesco Ltd.
- SEC CIK
- 0000914208
- Latest filing
- Aug 14, 2026
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q2 2026 holdings
- Shares (Q2 2026)
- 13,914
- Value
- $195.5K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 13,914 | $195.5K | <0.1% | +13,914 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −98,649−100.0% | Sold out | Holders |
| Q4 2025 | 98,649 | $3.04M | <0.1% | +98,649 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −12,809−100.0% | Sold out | Holders |
| Q2 2025 | 12,809 | $113.2K | <0.1% | −6,135−32.4% | ReducedConverted for a 1-for-20 split | Holders |
| Q1 2025 | 378,880 | $203.8K | <0.1% | −28,325−7.0% | Reduced | Holders |
| Q4 2024 | 407,205 | $260.6K | <0.1% | +1,256+0.3% | Added | Holders |
| Q3 2024 | 405,949 | $560.2K | <0.1% | −916−0.2% | Reduced | Holders |
| Q2 2024 | 406,865 | $590.0K | <0.1% | −2,541−0.6% | Reduced | Holders |
| Q1 2024 | 409,406 | $913.0K | <0.1% | +98,297+31.6% | Added | Holders |
| Q4 2023 | 311,109 | $603.6K | <0.1% | +18,397+6.3% | Added | Holders |
| Q3 2023 | 292,712 | $430.3K | <0.1% | +2,051+0.7% | Added | Holders |
| Q2 2023 | 290,661 | $924.3K | <0.1% | +1,475+0.5% | Added | Holders |
| Q1 2023 | 289,186 | $682.5K | <0.1% | +233,514+419.4% | Added | Holders |
| Q4 2022 | 55,672 | $193.2K | <0.1% | −255,324−82.1% | Reduced | Holders |
| Q3 2022 | 310,996 | $2.28M | <0.1% | +254,876+454.2% | Added | Holders |
| Q2 2022 | 56,120 | $366.0K | <0.1% | −2,564−4.4% | Reduced | Holders |
| Q1 2022 | 58,684 | $296.0K | <0.1% | +47,145+408.6% | Added | Holders |
| Q4 2021 | 11,539 | $89.0K | <0.1% | +11,539 | New | Holders |